SRT-2104

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSRT-2104
Drug Alias NameGSK-2245840SRT-2104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent deacetylase sirtuin 1 stimulants
TargetsNAD-dependent deacetylase sirtuin 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2PsoriasisMuscular Atrophy +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesUkraine +[11] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSirtris Pharmaceuticals IncGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2PsoriasisMuscular Atrophy +[6] 

Other Information

ATC CodeN/A
Related LinksN/A